Funding for this research was provided by:
German Cancer Consortium
Deutsche Krebshilfe (TransLUMINAL-B)
Received: 16 January 2018
Accepted: 16 April 2018
First Online: 24 April 2018
Ethics approval and consent to participate
: Generation and analysis of the data presented as use case was approved by the ethics board of the Charité Hospital (Reference number EA1/139/05 Amendment 2008).
: The authors declare that they have no competing interests.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.